GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurizon Therapeutics Ltd (FRA:ECQ0) » Definitions » Inventories, Raw Materials & Components

Neurizon Therapeutics (FRA:ECQ0) Inventories, Raw Materials & Components : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Neurizon Therapeutics Inventories, Raw Materials & Components?

Neurizon Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2024 was €0.00 Mil.


Neurizon Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Neurizon Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurizon Therapeutics Inventories, Raw Materials & Components Chart

Neurizon Therapeutics Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial - - - - -

Neurizon Therapeutics Semi-Annual Data
Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Jun24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neurizon Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Neurizon Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
96-100 Albert Road, Level 4, South Melbourne, Melbourne, VIC, AUS, 3205
Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Neurizon Therapeutics Headlines

No Headlines